FDA Approves First MCT8 Deficiency Treatment: Emcitate for Peripheral Thyrotoxicosis
FDA approves Emcitate, the first treatment for MCT8 deficiency, lowering excess thyroid hormone levels and easing cardiovascular and metabolic symptoms.
By Dr. A. Nikhil Krishnan, MBBS
·
Oct 17, 2026
·
5 min read